Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 3 for:    carrimycin

The Clinical Study of Carrimycin on Treatment Patients With COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04286503
Recruitment Status : Not yet recruiting
First Posted : February 27, 2020
Last Update Posted : February 27, 2020
Sponsor:
Collaborators:
Shenyang Tonglian Group CO., Ltd
Institute of Medicine and Biotechnology, Chinese Academy of Medical Sciences
Huangshi Central Hospital, China
Shenyang Pharmaceutical University
First Affiliated Hospital of Chongqing Medical University
The Second Affiliated Hospital of Harbin Medical University
No.2 People's Hospital of Fuyang City
First Affiliated Hospital Bengbu Medical College
Renmin Hospital of Wuhan University
The Sixth People's Hospital of Shenyang
Nanyang Central Hospital
Information provided by (Responsible Party):
Jin Ronghua, Beijing YouAn Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : February 28, 2021
Estimated Study Completion Date : February 28, 2021